Companies / Regatta Bio
Regatta Bio
Company
Regatta Bio is advancing the next generation of regulatory T cell therapies to address challenges in immune health
Regatta Bio has 2 investors on file, among them Eos BioInnovation and Panacea Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Eos BioInnovation
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Eos BioInnovation's full profile · Who invests alongside it
More from Panacea Capital
21 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Panacea Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Regatta Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Eos BioInnovation adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/regatta.bio/investors
# also
GET /v1/companies/regatta.bio
GET /v1/companies/regatta.bio/news